Skip to content
Delayed ~15 min

RNAC CARTESIAN THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 9 analyst firms say about CARTESIAN THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

7.53 USD+0.75 (+11.06%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+347.1%to the avg target 33.67 USD+26.14 USD
Buy 7 · Hold 1 · Sell 0

8 rated views · 9 analyst/firm records · 9 firms

Latest report30 Sep 2026avg report date 6 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8064
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8030

Recent analyst activity · last 90 days

Our tracked history has 4 reports on RNAC from 4 analyst firms in the last 90 days (9 firms in the past year).

Comparing each firm's latest target with its previous one: 3 left it unchanged.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BTIGJulian HarrisonBuy9 Jun 202644.00 USD
Cantor FitzgeraldKristen KluskaBuy9 Mar 202616.00 USD
H.C. WainwrightMitchell S. KapoorBuy30 Sep 202625.00 USD
Leerink PartnersThomas J SmithBuy1 May 202639.00 USD
NeedhamGil BlumBuy29 Sep 202640.00 USD
TD CowenTyler Van BurenBuy24 Mar 2026—
WedbushMartin FanBuy18 Aug 202638.00 USD
Weiss RatingsUnnamed analyst—9 Sep 2026—
Data feed RESEARCHResearch TeamHold29 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.